Loading
Latest filing published 01 May 2019 for Avivagen Inc., €19k.
No signal scores available.
Jeffrey Jay Kraws appears in our data through filings on Avivagen Inc. shares, published by SEDI. In total, 2 filings cover trades dated from 11 April 2017 to 30 April 2019.
Purchases make up the whole of the open-market record (1 purchase, €19k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2019: 1 purchase and no sales on the market.
The newest entry dates from 1 May 2019: an open-market purchase of €19k, in Avivagen Inc. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations